| ID: | 126 | |
|---|---|---|
| Name: | Compound 126 | |
| Description: | Original numeration in publication: 10 | |
| Labels: | Training_set, Thiazolidine‐2, 4‐dione | |
| CAS: | ||
| InChi Code: | InChI=1S/C19H13ClN2O5S/c20-13-5-1-11(2-6-13)9-15-17(24)22(19(27)28-15)10-16(23)21-14-7-3-12(4-8-14)18(25)26/h1-9H,10H2,(H,21,23)(H,25,26)/b15-9- |
pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]
| Value | Source or prediction |
|---|---|
| 6.54 |
El-Adl, K.; Sakr, H.; El-Hddad, S. S. A. a. E.-H., A.-G. A.; Nasser, M.; Abulkhair, H. S. Design, synthesis, docking, ADMET profile, and anticancer evaluations of novel thiazolidine-2,4-dione derivatives as VEGFR-2 inhibitors. Arch. Pharm. (Weinheim) 2021, 354, e2000491. https://doi.org/10.1002/ardp.202000491 |
| 6.42991 |
Eq1: VEGFR-2 inhibition (Data used to train model) |